| Luye Pharma Group, a Chinese drugmaker backed by Singapore’s sovereign wealth fund, and the company’s owners are poised to raise US$764 million (S$952 million) from a Hong Kong initial public offering (IPO), sources said.
The company plans to sell shares at HK$5.92 (S$0.952) apiece, the top end of a marketed range that started at HK$5.38, said the sources. Luye Pharma and existing investors, including Singapore’s GIC, offered 999.6 million shares in the sale, the firm’s IPO prospectus showed...............................................Full Article: Source
|